Relapse assessment following allogeneic SCT in patients with MDS and AML.
about
Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AMLDroplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation.Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with myelodysplastic syndromes.Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach.
P2860
Relapse assessment following allogeneic SCT in patients with MDS and AML.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Relapse assessment following allogeneic SCT in patients with MDS and AML.
@en
type
label
Relapse assessment following allogeneic SCT in patients with MDS and AML.
@en
prefLabel
Relapse assessment following allogeneic SCT in patients with MDS and AML.
@en
P2860
P1433
P1476
Relapse assessment following allogeneic SCT in patients with MDS and AML.
@en
P2093
Maximilian Christopeit
Nicolaus Kröger
P2860
P304
P356
10.1007/S00277-014-2046-8
P577
2014-03-27T00:00:00Z